SCHEMBL25834205

SCHEMBL25834205

CCOCC[N+](C)(C)CCCCCCC[N+](C)(C)CCOCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.52
DNM1 Q05193 8/20 0.50
HRH3 Q9Y5N1 2/20 0.43
MLNR O43193 1/20 0.43
NR1I2 O75469 1/20 0.43
ESR1 P03372 1/20 0.43
NR3C1 P04150 1/20 0.43
PGR P06401 1/20 0.43
ADRB2 P07550 1/20 0.43
CHRM2 P08172 1/20 0.43
ADRB1 P08588 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD2 P14416 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
CHRM3 P20309 1/20 0.43
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834213 1.00 HTT (0.52) HTTDNM1HRH3MLNRNR1I2
SCHEMBL25834209 1.00 HTT (0.52) HTTDNM1HRH3MLNRNR1I2
Hydrochloric Acid SCHEMBL9420706 0.91 HTT (0.62) HTTDNM1HRH3MLNRNR1I2
Bromide SCHEMBL10492766 0.91 DNM1 (0.64) HTTDNM1HRH3MLNRNR1I2
Fluoride Ion SCHEMBL9761233 0.91 HTT (0.62) HTTDNM1HRH3MLNRNR1I2
SCHEMBL17418953 0.89 ALDH1A1 (0.43) HTTDNM1HRH3MLNRNR1I2
SCHEMBL25834249 0.88 HTT (0.39) HTTDNM1HRH3MLNRNR1I2
Hydrochloric Acid SCHEMBL30869372 0.87 ALDH1A1 (0.41) HTTDNM1HRH3MLNRNR1I2
Bromide SCHEMBL30869335 0.87 ALDH1A1 (0.41) HTTDNM1HRH3MLNRNR1I2
Iodide SCHEMBL30869362 0.87 ALDH1A1 (0.41) HTTDNM1HRH3MLNRNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents HACD3, C9, HACD2 HTT 657/4885DNM1 1502/4885HRH3 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.